Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 5.11437424 |
2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.11133898 |
3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.70681932 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 4.70681932 |
5 | cytidine deamination (GO:0009972) | 4.50782806 |
6 | cytidine metabolic process (GO:0046087) | 4.50782806 |
7 | cytidine catabolic process (GO:0006216) | 4.50782806 |
8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.26431928 |
9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.06031678 |
10 | respiratory electron transport chain (GO:0022904) | 4.01116138 |
11 | electron transport chain (GO:0022900) | 3.96778836 |
12 | protein complex biogenesis (GO:0070271) | 3.93702756 |
13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.87463486 |
14 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.72269259 |
15 | chaperone-mediated protein transport (GO:0072321) | 3.71445838 |
16 | protein neddylation (GO:0045116) | 3.62290632 |
17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.57573529 |
18 | response to interferon-beta (GO:0035456) | 3.55245258 |
19 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.47455936 |
20 | NADH dehydrogenase complex assembly (GO:0010257) | 3.47455936 |
21 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.47455936 |
22 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.45823890 |
23 | proteasome assembly (GO:0043248) | 3.41594821 |
24 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40489847 |
25 | cytochrome complex assembly (GO:0017004) | 3.31362956 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.28360394 |
27 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.26896562 |
28 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.26896562 |
29 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.26896562 |
30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.26768621 |
31 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.24443575 |
32 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.24443575 |
33 | ribosomal small subunit assembly (GO:0000028) | 3.20257867 |
34 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.18010881 |
35 | respiratory chain complex IV assembly (GO:0008535) | 3.14147329 |
36 | rRNA modification (GO:0000154) | 3.09448492 |
37 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.06340135 |
38 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.06340135 |
39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04479253 |
40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.01958955 |
41 | positive regulation of defense response to virus by host (GO:0002230) | 3.01822672 |
42 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.99877417 |
43 | platelet dense granule organization (GO:0060155) | 2.99591640 |
44 | hydrogen ion transmembrane transport (GO:1902600) | 2.98732799 |
45 | cellular response to zinc ion (GO:0071294) | 2.97796513 |
46 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.89403238 |
47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88781218 |
48 | negative regulation of ligase activity (GO:0051352) | 2.88781218 |
49 | viral transcription (GO:0019083) | 2.83645070 |
50 | ribosomal small subunit biogenesis (GO:0042274) | 2.81920191 |
51 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.79842749 |
52 | proton transport (GO:0015992) | 2.79037467 |
53 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.77994539 |
54 | cellular response to interferon-beta (GO:0035458) | 2.77205409 |
55 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.76670840 |
56 | pseudouridine synthesis (GO:0001522) | 2.74500522 |
57 | mannosylation (GO:0097502) | 2.74240683 |
58 | hydrogen transport (GO:0006818) | 2.73524005 |
59 | cotranslational protein targeting to membrane (GO:0006613) | 2.73153054 |
60 | translational termination (GO:0006415) | 2.71961986 |
61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.71085625 |
62 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.70571631 |
63 | * protein targeting to ER (GO:0045047) | 2.70555204 |
64 | maturation of SSU-rRNA (GO:0030490) | 2.69033657 |
65 | mast cell activation (GO:0045576) | 2.68646375 |
66 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.68389589 |
67 | ATP biosynthetic process (GO:0006754) | 2.67683452 |
68 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.67644069 |
69 | negative T cell selection (GO:0043383) | 2.66494800 |
70 | cellular response to interleukin-15 (GO:0071350) | 2.66223132 |
71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64994858 |
72 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.64790544 |
73 | regulation of chronic inflammatory response (GO:0002676) | 2.64479972 |
74 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.59038897 |
75 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.59038897 |
76 | * protein localization to endoplasmic reticulum (GO:0070972) | 2.58936490 |
77 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.58622272 |
78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.57794190 |
79 | protein targeting to mitochondrion (GO:0006626) | 2.57679588 |
80 | regulation of regulatory T cell differentiation (GO:0045589) | 2.57317283 |
81 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.57098301 |
82 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.56995605 |
83 | GTP biosynthetic process (GO:0006183) | 2.55629668 |
84 | immunoglobulin mediated immune response (GO:0016064) | 2.55622564 |
85 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.54638342 |
86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.53162211 |
87 | establishment of protein localization to mitochondrion (GO:0072655) | 2.52702146 |
88 | positive regulation of ligase activity (GO:0051351) | 2.51478697 |
89 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51029404 |
90 | termination of RNA polymerase III transcription (GO:0006386) | 2.50048425 |
91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.50048425 |
92 | positive regulation of cell cycle arrest (GO:0071158) | 2.50002501 |
93 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.49007164 |
94 | regulation of cellular amine metabolic process (GO:0033238) | 2.48936197 |
95 | negative regulation of telomere maintenance (GO:0032205) | 2.47488140 |
96 | translational elongation (GO:0006414) | 2.46960001 |
97 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.43515537 |
98 | rRNA methylation (GO:0031167) | 2.42707412 |
99 | negative thymic T cell selection (GO:0045060) | 2.42095542 |
100 | translation (GO:0006412) | 2.41150656 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70053041 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.22509108 |
3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.99377554 |
4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.83816381 |
5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.82115107 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61832152 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.25735823 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.21213115 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19934477 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.03423320 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.98675519 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90905537 |
13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.84304764 |
14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.75584489 |
15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.72030650 |
16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.71577169 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51810356 |
18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30605869 |
19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.29280042 |
20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.26858663 |
21 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.26115776 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05182370 |
23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.00545746 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.99331349 |
25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.99312593 |
26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96053335 |
27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95767532 |
28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92505437 |
29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.89193410 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80910194 |
31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.77792938 |
32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77258070 |
33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65618257 |
34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61388508 |
35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.60567836 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59194577 |
37 | MYB_26560356_Chip-Seq_TH2_Human | 1.54828115 |
38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50931028 |
39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49682980 |
40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.48739806 |
41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47791282 |
42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43105060 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41615836 |
44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39290921 |
45 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.38128063 |
46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36260898 |
47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35990285 |
48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35510422 |
49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35251468 |
50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34313871 |
51 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.31751723 |
52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25253368 |
53 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24200158 |
54 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.22851182 |
55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21064471 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20633207 |
57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20064088 |
58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16223474 |
59 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.15745323 |
60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14899223 |
61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14792224 |
62 | MYB_26560356_Chip-Seq_TH1_Human | 1.13115471 |
63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13007671 |
64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10378293 |
65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09519651 |
66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07654487 |
67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07114333 |
68 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06933949 |
69 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06183942 |
70 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06183942 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05223763 |
72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03954053 |
73 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.03311247 |
74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01441574 |
75 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99878845 |
76 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99558927 |
77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99448785 |
78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98951091 |
79 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98423243 |
80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97219348 |
81 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94749354 |
82 | P300_27268052_Chip-Seq_Bcells_Human | 0.94518355 |
83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93982593 |
84 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93659192 |
85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93165354 |
86 | MAF_26560356_Chip-Seq_TH2_Human | 0.92835224 |
87 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92523000 |
88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92335318 |
89 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92132476 |
90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91471949 |
91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89913192 |
92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89793005 |
93 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.89738930 |
94 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89337806 |
95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88066085 |
96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87873547 |
97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.86287602 |
98 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.85919225 |
99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85880757 |
100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84305209 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 4.05892844 |
2 | MP0005671_abnormal_response_to | 4.02414101 |
3 | MP0001835_abnormal_antigen_presentation | 3.03717817 |
4 | MP0009785_altered_susceptibility_to | 2.96806280 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.64152853 |
6 | MP0000685_abnormal_immune_system | 2.58110573 |
7 | MP0001800_abnormal_humoral_immune | 2.56594055 |
8 | MP0001790_abnormal_immune_system | 2.52491053 |
9 | MP0005387_immune_system_phenotype | 2.52491053 |
10 | MP0005000_abnormal_immune_tolerance | 2.38842754 |
11 | MP0003763_abnormal_thymus_physiology | 2.27754483 |
12 | MP0003724_increased_susceptibility_to | 2.26573252 |
13 | MP0005025_abnormal_response_to | 2.23681625 |
14 | MP0002723_abnormal_immune_serum | 2.17875749 |
15 | MP0002420_abnormal_adaptive_immunity | 2.09984686 |
16 | MP0002452_abnormal_antigen_presenting | 2.09117090 |
17 | MP0009333_abnormal_splenocyte_physiolog | 2.08942601 |
18 | MP0001819_abnormal_immune_cell | 2.06114210 |
19 | MP0006082_CNS_inflammation | 1.94756277 |
20 | MP0003436_decreased_susceptibility_to | 1.94412730 |
21 | MP0005075_abnormal_melanosome_morpholog | 1.92539332 |
22 | MP0006036_abnormal_mitochondrial_physio | 1.83461515 |
23 | MP0002132_abnormal_respiratory_system | 1.76931829 |
24 | MP0002277_abnormal_respiratory_mucosa | 1.76098711 |
25 | MP0003186_abnormal_redox_activity | 1.73536586 |
26 | MP0002419_abnormal_innate_immunity | 1.72727007 |
27 | MP0001853_heart_inflammation | 1.69224942 |
28 | MP0006072_abnormal_retinal_apoptosis | 1.65656850 |
29 | MP0003011_delayed_dark_adaptation | 1.62581576 |
30 | MP0001845_abnormal_inflammatory_respons | 1.60974683 |
31 | MP0002405_respiratory_system_inflammati | 1.60404415 |
32 | MP0002837_dystrophic_cardiac_calcinosis | 1.59139568 |
33 | MP0009764_decreased_sensitivity_to | 1.57637764 |
34 | MP0000716_abnormal_immune_system | 1.57236052 |
35 | MP0001764_abnormal_homeostasis | 1.52075661 |
36 | MP0000372_irregular_coat_pigmentation | 1.51091475 |
37 | MP0002138_abnormal_hepatobiliary_system | 1.49159692 |
38 | MP0002398_abnormal_bone_marrow | 1.48956072 |
39 | MP0005084_abnormal_gallbladder_morpholo | 1.44581181 |
40 | MP0003195_calcinosis | 1.43503305 |
41 | MP0000689_abnormal_spleen_morphology | 1.39778146 |
42 | MP0001905_abnormal_dopamine_level | 1.35569689 |
43 | MP0002163_abnormal_gland_morphology | 1.35151355 |
44 | MP0008469_abnormal_protein_level | 1.32412151 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.30413589 |
46 | MP0008872_abnormal_physiological_respon | 1.28746615 |
47 | MP0008058_abnormal_DNA_repair | 1.26483629 |
48 | MP0002166_altered_tumor_susceptibility | 1.26005314 |
49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25001876 |
50 | MP0002429_abnormal_blood_cell | 1.24689193 |
51 | MP0002722_abnormal_immune_system | 1.23421347 |
52 | MP0003646_muscle_fatigue | 1.22839653 |
53 | MP0010155_abnormal_intestine_physiology | 1.21822839 |
54 | MP0001873_stomach_inflammation | 1.17653344 |
55 | MP0002876_abnormal_thyroid_physiology | 1.16506819 |
56 | MP0003866_abnormal_defecation | 1.16030646 |
57 | MP0000703_abnormal_thymus_morphology | 1.12792589 |
58 | MP0005253_abnormal_eye_physiology | 1.09821224 |
59 | MP0010386_abnormal_urinary_bladder | 1.09409376 |
60 | MP0005379_endocrine/exocrine_gland_phen | 1.08700883 |
61 | MP0002006_tumorigenesis | 1.08546304 |
62 | MP0005310_abnormal_salivary_gland | 1.08222170 |
63 | MP0001968_abnormal_touch/_nociception | 1.08156562 |
64 | MP0003786_premature_aging | 1.07062454 |
65 | MP0004147_increased_porphyrin_level | 1.06962857 |
66 | MP0001533_abnormal_skeleton_physiology | 1.05508250 |
67 | MP0005410_abnormal_fertilization | 1.03682984 |
68 | MP0001919_abnormal_reproductive_system | 0.99373142 |
69 | MP0006035_abnormal_mitochondrial_morpho | 0.99195149 |
70 | MP0002693_abnormal_pancreas_physiology | 0.99002067 |
71 | MP0002736_abnormal_nociception_after | 0.97626996 |
72 | MP0005551_abnormal_eye_electrophysiolog | 0.97330297 |
73 | MP0004381_abnormal_hair_follicle | 0.94434861 |
74 | MP0002102_abnormal_ear_morphology | 0.92772468 |
75 | MP0005646_abnormal_pituitary_gland | 0.91264136 |
76 | MP0003172_abnormal_lysosome_physiology | 0.91232788 |
77 | MP0005464_abnormal_platelet_physiology | 0.88642162 |
78 | MP0002933_joint_inflammation | 0.87928419 |
79 | MP0001986_abnormal_taste_sensitivity | 0.86872844 |
80 | MP0005174_abnormal_tail_pigmentation | 0.86360526 |
81 | MP0002638_abnormal_pupillary_reflex | 0.85653351 |
82 | MP0000343_altered_response_to | 0.85104198 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.85058087 |
84 | MP0005645_abnormal_hypothalamus_physiol | 0.84509195 |
85 | MP0008877_abnormal_DNA_methylation | 0.84274682 |
86 | MP0003693_abnormal_embryo_hatching | 0.81261379 |
87 | MP0004142_abnormal_muscle_tone | 0.81237322 |
88 | MP0003136_yellow_coat_color | 0.80812233 |
89 | MP0001501_abnormal_sleep_pattern | 0.79929525 |
90 | MP0005389_reproductive_system_phenotype | 0.79738512 |
91 | MP0009763_increased_sensitivity_to | 0.77923510 |
92 | MP0009379_abnormal_foot_pigmentation | 0.77551177 |
93 | MP0005166_decreased_susceptibility_to | 0.77427187 |
94 | MP0001984_abnormal_olfaction | 0.77242882 |
95 | MP0005636_abnormal_mineral_homeostasis | 0.76877210 |
96 | MP0002653_abnormal_ependyma_morphology | 0.75986441 |
97 | MP0002095_abnormal_skin_pigmentation | 0.74227568 |
98 | MP0003075_altered_response_to | 0.72141955 |
99 | MP0005058_abnormal_lysosome_morphology | 0.71899672 |
100 | MP0008873_increased_physiological_sensi | 0.71245201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Mitochondrial inheritance (HP:0001427) | 4.34423645 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 4.26938780 |
3 | Lipid accumulation in hepatocytes (HP:0006561) | 4.09660666 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.96058541 |
5 | 3-Methylglutaconic aciduria (HP:0003535) | 3.95768660 |
6 | Increased hepatocellular lipid droplets (HP:0006565) | 3.87049832 |
7 | Increased CSF lactate (HP:0002490) | 3.86241389 |
8 | Acute encephalopathy (HP:0006846) | 3.78882249 |
9 | Hepatocellular necrosis (HP:0001404) | 3.62206489 |
10 | Progressive macrocephaly (HP:0004481) | 3.56146280 |
11 | Renal Fanconi syndrome (HP:0001994) | 3.50470667 |
12 | Hepatic necrosis (HP:0002605) | 3.44350782 |
13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.43790919 |
14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40315447 |
15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40315447 |
16 | Increased muscle lipid content (HP:0009058) | 3.34233611 |
17 | Stomatitis (HP:0010280) | 3.32899207 |
18 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.27970986 |
19 | IgG deficiency (HP:0004315) | 3.21154862 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.08376918 |
21 | Exertional dyspnea (HP:0002875) | 3.04637554 |
22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.90708181 |
23 | Abnormal number of erythroid precursors (HP:0012131) | 2.78061325 |
24 | Aplastic anemia (HP:0001915) | 2.66661624 |
25 | Severe combined immunodeficiency (HP:0004430) | 2.66271217 |
26 | Lactic acidosis (HP:0003128) | 2.62567750 |
27 | Pancreatic cysts (HP:0001737) | 2.61453916 |
28 | Type I transferrin isoform profile (HP:0003642) | 2.60085056 |
29 | Cerebral edema (HP:0002181) | 2.59699925 |
30 | Abnormality of T cell number (HP:0011839) | 2.59261811 |
31 | T lymphocytopenia (HP:0005403) | 2.53963407 |
32 | Increased serum lactate (HP:0002151) | 2.50793753 |
33 | Abnormality of B cell number (HP:0010975) | 2.48669897 |
34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48025724 |
35 | Increased IgM level (HP:0003496) | 2.46809204 |
36 | Optic disc pallor (HP:0000543) | 2.45336958 |
37 | Abnormality of T cells (HP:0002843) | 2.45253112 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42870715 |
39 | Congenital stationary night blindness (HP:0007642) | 2.41760775 |
40 | Eosinophilia (HP:0001880) | 2.41407310 |
41 | Generalized aminoaciduria (HP:0002909) | 2.39816751 |
42 | Respiratory difficulties (HP:0002880) | 2.35959124 |
43 | Respiratory failure (HP:0002878) | 2.34242963 |
44 | Abnormality of eosinophils (HP:0001879) | 2.31490079 |
45 | B lymphocytopenia (HP:0010976) | 2.31387771 |
46 | IgM deficiency (HP:0002850) | 2.31029252 |
47 | Panhypogammaglobulinemia (HP:0003139) | 2.28997161 |
48 | Reduced antithrombin III activity (HP:0001976) | 2.27236028 |
49 | Abnormality of renal resorption (HP:0011038) | 2.25938294 |
50 | Abnormality of the prostate (HP:0008775) | 2.22909656 |
51 | Abnormal protein glycosylation (HP:0012346) | 2.22347046 |
52 | Abnormal glycosylation (HP:0012345) | 2.22347046 |
53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.22347046 |
54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.22347046 |
55 | Exercise intolerance (HP:0003546) | 2.21025469 |
56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18998082 |
57 | Lethargy (HP:0001254) | 2.18850587 |
58 | Combined immunodeficiency (HP:0005387) | 2.17808318 |
59 | Recurrent fungal infections (HP:0002841) | 2.17398967 |
60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16576327 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.16576327 |
62 | Pancytopenia (HP:0001876) | 2.15034661 |
63 | Autoimmune hemolytic anemia (HP:0001890) | 2.13080170 |
64 | Chronic sinusitis (HP:0011109) | 2.12450827 |
65 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11075943 |
66 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09893060 |
67 | Thyroiditis (HP:0100646) | 2.09369013 |
68 | Abolished electroretinogram (ERG) (HP:0000550) | 2.08969041 |
69 | Methylmalonic aciduria (HP:0012120) | 2.08745008 |
70 | Glycosuria (HP:0003076) | 2.07967705 |
71 | Abnormality of urine glucose concentration (HP:0011016) | 2.07967705 |
72 | Mediastinal lymphadenopathy (HP:0100721) | 2.07100788 |
73 | Agammaglobulinemia (HP:0004432) | 2.06505777 |
74 | Encephalitis (HP:0002383) | 2.06460036 |
75 | Granulocytopenia (HP:0001913) | 2.06246838 |
76 | Abnormality of T cell physiology (HP:0011840) | 2.05961704 |
77 | Meningitis (HP:0001287) | 2.04115291 |
78 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.04004512 |
79 | True hermaphroditism (HP:0010459) | 2.03422770 |
80 | Pulmonary infiltrates (HP:0002113) | 2.03233497 |
81 | Pancreatic fibrosis (HP:0100732) | 2.01597569 |
82 | Retrobulbar optic neuritis (HP:0100654) | 1.98942812 |
83 | Optic neuritis (HP:0100653) | 1.98942812 |
84 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97118908 |
85 | Obstructive lung disease (HP:0006536) | 1.97118908 |
86 | Oral leukoplakia (HP:0002745) | 1.96457457 |
87 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94526319 |
88 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94526319 |
89 | Autoimmune thrombocytopenia (HP:0001973) | 1.93899231 |
90 | Myositis (HP:0100614) | 1.89696340 |
91 | Neutropenia (HP:0001875) | 1.89587122 |
92 | Hypoproteinemia (HP:0003075) | 1.89075023 |
93 | CNS demyelination (HP:0007305) | 1.88369571 |
94 | Vacuolated lymphocytes (HP:0001922) | 1.87481201 |
95 | Renal cortical cysts (HP:0000803) | 1.86022906 |
96 | Hypothermia (HP:0002045) | 1.85767410 |
97 | Leukocytosis (HP:0001974) | 1.84701127 |
98 | Abnormality of midbrain morphology (HP:0002418) | 1.84622112 |
99 | Molar tooth sign on MRI (HP:0002419) | 1.84622112 |
100 | Vasculitis (HP:0002633) | 1.84320629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 3.77959001 |
2 | VRK2 | 3.76785542 |
3 | TAOK3 | 3.42193894 |
4 | ZAK | 2.77982610 |
5 | TESK2 | 2.70993595 |
6 | PINK1 | 2.69479349 |
7 | MAP4K1 | 2.60827128 |
8 | ADRBK2 | 2.51035603 |
9 | TLK1 | 2.49895394 |
10 | MST4 | 2.31946414 |
11 | NME2 | 2.27278719 |
12 | MAP4K2 | 2.17212761 |
13 | MARK3 | 2.13169966 |
14 | KDR | 2.09789015 |
15 | NUAK1 | 2.04678942 |
16 | GRK1 | 2.01414393 |
17 | STK16 | 1.95538386 |
18 | VRK1 | 1.89453364 |
19 | FRK | 1.81706844 |
20 | BCKDK | 1.81629265 |
21 | BMPR1B | 1.81017996 |
22 | NME1 | 1.66298164 |
23 | IKBKB | 1.54998733 |
24 | EIF2AK3 | 1.47331883 |
25 | ITK | 1.38754819 |
26 | SYK | 1.31522660 |
27 | MAPKAPK3 | 1.30698477 |
28 | KIT | 1.30464295 |
29 | RIPK4 | 1.27248574 |
30 | FES | 1.26062429 |
31 | PRKCQ | 1.25276527 |
32 | IKBKE | 1.21010165 |
33 | GRK6 | 1.17435602 |
34 | MAP3K12 | 1.14455926 |
35 | TYK2 | 1.12970966 |
36 | TEC | 1.08221818 |
37 | TNK2 | 1.08186507 |
38 | BTK | 1.07766664 |
39 | WNK3 | 1.03400328 |
40 | DYRK2 | 1.02190739 |
41 | LYN | 0.97860204 |
42 | MATK | 0.93984814 |
43 | NLK | 0.93345669 |
44 | GRK7 | 0.89905284 |
45 | MYLK | 0.89612284 |
46 | RPS6KA5 | 0.88814864 |
47 | EIF2AK1 | 0.88010959 |
48 | IRAK4 | 0.87685961 |
49 | CSNK1G3 | 0.84718379 |
50 | TBK1 | 0.84317452 |
51 | MAP3K11 | 0.84296656 |
52 | PDK2 | 0.81797815 |
53 | LCK | 0.81254353 |
54 | TIE1 | 0.75515637 |
55 | BUB1 | 0.75435764 |
56 | CSK | 0.75124273 |
57 | SRPK1 | 0.72612980 |
58 | CAMKK2 | 0.71581330 |
59 | BLK | 0.70858521 |
60 | ZAP70 | 0.70121325 |
61 | CSF1R | 0.66134443 |
62 | MAP2K7 | 0.65627794 |
63 | CSNK1A1L | 0.64390629 |
64 | PIM2 | 0.62926852 |
65 | DAPK1 | 0.60416849 |
66 | CSNK1G1 | 0.59356180 |
67 | MAP3K14 | 0.59286204 |
68 | MAP2K6 | 0.58852427 |
69 | TGFBR1 | 0.57806161 |
70 | JAK3 | 0.54811456 |
71 | INSRR | 0.54126437 |
72 | OXSR1 | 0.53012374 |
73 | CSNK1G2 | 0.52559694 |
74 | RPS6KA4 | 0.52162210 |
75 | PIM1 | 0.51058020 |
76 | FGR | 0.50414588 |
77 | GRK5 | 0.49299405 |
78 | ADRBK1 | 0.48624534 |
79 | CSNK2A1 | 0.47724134 |
80 | WNK4 | 0.46603578 |
81 | MAPKAPK5 | 0.45975820 |
82 | TESK1 | 0.44731328 |
83 | ACVR1B | 0.42155942 |
84 | CSNK2A2 | 0.39089867 |
85 | CSNK1A1 | 0.38562743 |
86 | MAPK15 | 0.37983315 |
87 | CDC7 | 0.37132669 |
88 | JAK1 | 0.36708802 |
89 | MAP3K5 | 0.35257820 |
90 | HCK | 0.34587183 |
91 | MAP2K2 | 0.33834538 |
92 | MAPK13 | 0.32744735 |
93 | PLK3 | 0.32084247 |
94 | MUSK | 0.30839175 |
95 | IGF1R | 0.30565133 |
96 | ILK | 0.30223792 |
97 | CDK3 | 0.29410585 |
98 | NEK2 | 0.28850694 |
99 | PRKCD | 0.28227368 |
100 | ABL1 | 0.27917099 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.42551692 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.90350402 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.25161166 |
4 | Ribosome_Homo sapiens_hsa03010 | 3.18241193 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.16853650 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.46346914 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40941910 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.40523916 |
9 | Protein export_Homo sapiens_hsa03060 | 2.37884977 |
10 | Asthma_Homo sapiens_hsa05310 | 2.25321321 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15732868 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10654755 |
13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.09556340 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08295615 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00360789 |
16 | RNA polymerase_Homo sapiens_hsa03020 | 2.00349606 |
17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.96100125 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82672792 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56661149 |
20 | Homologous recombination_Homo sapiens_hsa03440 | 1.53003229 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51854837 |
22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46809556 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44797967 |
24 | Phototransduction_Homo sapiens_hsa04744 | 1.44347270 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34959007 |
26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.30743238 |
27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25464204 |
28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21518919 |
29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21430923 |
30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.19261994 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16623016 |
32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14763353 |
33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12045703 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10671828 |
35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10557187 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.09337468 |
37 | DNA replication_Homo sapiens_hsa03030 | 1.06215101 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98407352 |
39 | RNA degradation_Homo sapiens_hsa03018 | 0.95923769 |
40 | Mismatch repair_Homo sapiens_hsa03430 | 0.94590164 |
41 | Purine metabolism_Homo sapiens_hsa00230 | 0.89324179 |
42 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87723009 |
43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87116607 |
44 | Spliceosome_Homo sapiens_hsa03040 | 0.86183522 |
45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85488924 |
46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83896076 |
47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83022478 |
48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80557701 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77344107 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76974237 |
51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75574100 |
52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74652172 |
53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73333166 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73074817 |
55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72857700 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72156440 |
57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71571916 |
58 | Base excision repair_Homo sapiens_hsa03410 | 0.71534588 |
59 | Measles_Homo sapiens_hsa05162 | 0.69618857 |
60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69123117 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68479205 |
62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67838615 |
63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66363127 |
64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65268930 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64454231 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64051025 |
67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62958194 |
68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62051158 |
69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60729979 |
70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60020979 |
71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58763694 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58399255 |
73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58236580 |
74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57137261 |
75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53847871 |
76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53672484 |
77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52862354 |
78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52614989 |
79 | Mineral absorption_Homo sapiens_hsa04978 | 0.52558601 |
80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50068583 |
81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49177360 |
82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48578413 |
83 | Tuberculosis_Homo sapiens_hsa05152 | 0.48373775 |
84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47066017 |
85 | Lysosome_Homo sapiens_hsa04142 | 0.46547592 |
86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44194178 |
87 | Phagosome_Homo sapiens_hsa04145 | 0.44179950 |
88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41967951 |
89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41372949 |
90 | Legionellosis_Homo sapiens_hsa05134 | 0.38873605 |
91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37747768 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37672567 |
93 | Malaria_Homo sapiens_hsa05144 | 0.37216670 |
94 | Pertussis_Homo sapiens_hsa05133 | 0.36663445 |
95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36395360 |
96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35483060 |
97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35046575 |
98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34805820 |
99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33864816 |
100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33158433 |